Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

0.452
Delayed Data
As of 4:00pm ET
 -0.038 / -7.76%
Today’s Change
0.39
Today|||52-Week Range
8.75
-85.37%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close0.49
Today’s open0.46
Day’s range0.40 - 0.52
Volume752,407
Average volume (3 months)502,301
Market cap$12.8M
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+66.37%
Earnings growth (this year)+58.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+17,425.00%
P/E ratioNM
Price/Sales100.27
Price/Book0.33

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc0.000.00%
GNVCGenVec Inc-0.02-3.67%
RTTRRitter Pharmaceutica...+0.06+4.08%
CBIOCatalyst Biosciences...+0.27+21.60%
Data as of 4:00pm ET, 06/30/2016

Financials

Next reporting dateAugust 5, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$701.0K
Annual profit (last year)-$52.2M
Net profit margin-7,444.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Scott M. Rocklage
President &
Chief Operating Officer
Michael Wyand
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs